Shanghai New Yellow River Pharmaceutical

Shanghai Xin Huangpu Pharmaceutical is a China-based pharmaceutical company specializing in the research, development, and manufacturing of chemical drugs and biochemical preparations. The company focuses on several key therapeutic areas, including cardiovascular and cerebrovascular diseases, anti-infectives, and digestive system treatments. Its product portfolio includes notable drugs such as Argatroban for thrombosis and Enalapril for hypertension. Operating with modern GMP-certified facilities, the company integrates R&D with large-scale production to serve the domestic Chinese market. It is recognized for its expertise in synthetic chemistry and the production of high-quality generic medications.